Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-292022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 Absorption administration All participant anticipated Area assigned AUC C max center changes in clinical Concentration control group Corona Course COVID-19 CYP2D6 CYP3A4 dissemination dose drug drug-drug interaction element enrolment enzyme activity Enzymes EudraCT Germany HCQ Hydroxychloroquine Impact inhibitor investigator Microdosing Midazolam mononuclear cell not blinded number objective Open-label outcome P450 Pantoprazole parallel group participant Patient PBMC PBMCs performed Peripheral blood Phase I plasma PPI probe protocol randomisation list randomised randomised controlled trial Randomized receive recruitment Registered registry reported Sample size secondary single dose Standard status Study protocol target cell treated treatment group Trial trial protocol Two-arm university Volunteer website Whole blood Yohimbine [DOI] 10.1186/s13063-020-04476-y PMC 바로가기 [Article Type] Letter